Skip to main content

EU regulator starts ‘rolling review’ of China’s Sinovac COVID-19 vaccine

The European Medicines Agency has started a rolling review of China’s Sinovac COVID-19 vaccine to assess its effectiveness and safety, the first step toward possible authorization of the shot in the 27-member bloc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.